Amy Chung
University of Melbourne, Doherty Institute, VIC, Australia
- This delegate is presenting an abstract at this event.

Amy Chung leads the Systems Serology laboratory at the Department of Microbiology and Immunology, University of Melbourne at the Doherty Institute. Dr Chung completed her PhD at the University of Melbourne in 2011 and was awarded an NHMRC CJ Martin, American Australian Fellowship, and MGH Discovery Fellowship) to conduct a postdoc at the Ragon Institute of MGH, MIT and Harvard. She returned to the University of Melbourne, Peter Doherty Institute in 2015 and was awarded an NHMRC CDF and amfAR Mathilde Krim II Fellowship that helped her to establish her own laboratory in 2019. She is currently an NHMRC EL2 Investigator and Dame Kate Campbell Fellow. Her research focuses upon the application of cutting-edge experimental technologies, combined with advanced computational analysis to holistically examine functional antibodies against a range of infectious diseases including HIV, Mycobacterium Tuberculosis, Malaria and COVID-19.
Presentations this author is a contributor to:
Butyrophilin 3A1 interacts with the Vγ9Vδ2+ T cell receptor (#12)
5:50 PM
Tom S Fulford
Session 3: Adaptive Immunity
Robust and prototypical immune responses towards COVID-19 BNT162b2 vaccine in First Nations Australian people are impacted by co-morbidities (#19)
11:20 AM
Katherine Kedzierska
Session 6: Pandemic Preparedness I
High-throughput characterization of antibody responses in SARS-CoV-2 infection and vaccination (#9)
4:45 PM
Amy Chung
Session 3: Adaptive Immunity